Literature DB >> 6197893

Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis.

M J McMahon, M Bowen, A D Mayer, E H Cooper.   

Abstract

alpha 2-macroglobulin is probably the most important of the antiproteases in plasma. In this study, the relationships of plasma alpha 2-macroglobulin to the clinical features of acute pancreatitis as well as to plasma levels of other antiproteases, immunoglobulins, and immunoreactive trypsin, were investigated in 55 patients with acute pancreatitis. The mean level of alpha 2-macroglobulin in 395 plasma samples from the patients was 2.12 g/liter compared with 2.41 g/liter in 29 healthy subjects and 2.93 g/liter in 17 patients with septicemia. Plasma levels were lower in 12 patients with severe pancreatitis than in 43 with mild attacks, and the lowest levels in three fatal attacks were less than half the mean of the normal range. Lowest levels were recorded at a mean time of 3 days after admission in the patients with mild attacks, at 5 days after admission in the patients with severe attacks, and 9 days after admission in those with fatal attacks. In contrast, plasma levels of the alpha 1-proteinase inhibitor antichymotrypsin and C-reactive protein increased to above normal levels during the attack, significantly more so in severe compared with mild attacks. Plasma levels of IgA, IgG, and IgM remained within the normal range or were increased. In patients with severe pancreatitis, plasma levels of immunoreactive trypsin remained elevated for longer than in those with mild attacks although there was little initial difference in the levels. These data suggest that decreasing levels of alpha 2-macroglobulin during the course of acute pancreatitis are due to a specific mechanism and unrelated, for the most part, to any generalized effect of pancreatitis on protein synthesis. The formation of rapidly cleared complexes between alpha 2-macroglobulin and active proteases is the most tenable explanation for the depletion of plasma levels, but the clinical significance of the changes remains unclear.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197893     DOI: 10.1016/0002-9610(84)90052-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  31 in total

Review 1.  Current therapeutic strategies in severe acute pancreatitis.

Authors:  M S Reynaert; T Dugernier; P J Kestens
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

3.  A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis.

Authors:  T Leese; M Holliday; M Watkins; W M Thomas; J P Neoptolemos; C Hall; A Attard
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

Review 4.  Acute pancreatitis: assessment and management.

Authors:  P Skaife; A N Kingsnorth
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 5.  Organ Failure Due to Systemic Injury in Acute Pancreatitis.

Authors:  Pramod K Garg; Vijay P Singh
Journal:  Gastroenterology       Date:  2019-02-12       Impact factor: 22.682

6.  Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study.

Authors:  M Büchler; P Malfertheiner; C Schoetensack; W Uhl; H G Beger
Journal:  Int J Pancreatol       Date:  1986-10

7.  C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.

Authors:  P Puolakkainen; V Valtonen; A Paananen; T Schröder
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

8.  Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.

Authors:  J A Rivera; J Werner; A L Warshaw; K B Lewandrowski; D W Rattner; C Fernández del Castillo
Journal:  Int J Pancreatol       Date:  1998-04

9.  Monitoring of serum proteinase--antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Results of a prospective multicenter study.

Authors:  J E Domínguez-Muñoz; F Carballo; M J García; J Miguel de Diego; F Gea; J Yangüela; J de la Morena
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

10.  Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.

Authors:  Brendan J Kelly; Ebbing Lautenbach; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry D Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Jennifer H Han
Journal:  Diagn Microbiol Infect Dis       Date:  2016-01-08       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.